These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9690619)

  • 1. Activation of the c-fos serum response element by phosphatidyl inositol 3-kinase and rho pathways in HeLa cells.
    Wang Y; Falasca M; Schlessinger J; Malstrom S; Tsichlis P; Settleman J; Hu W; Lim B; Prywes R
    Cell Growth Differ; 1998 Jul; 9(7):513-22. PubMed ID: 9690619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of growth factor signals at the c-fos serum response element.
    Price MA; Hill C; Treisman R
    Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):551-9. PubMed ID: 8735278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for the small GTPase Rac in polyomavirus middle-T antigen-mediated activation of the serum response element and in cell transformation.
    Urich M; Senften M; Shaw PE; Ballmer-Hofer K
    Oncogene; 1997 Mar; 14(10):1235-41. PubMed ID: 9121774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequences at the 3' side of the c-fos SRE mediate gene expression via an Sob1-dependent, TCF-independent pathway.
    Omoike OI; Benson BA; Chan MA; Benedict SH
    Biochem Biophys Res Commun; 1999 Aug; 262(2):523-9. PubMed ID: 10462507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-fos serum response element (SRE) confers negative response to glucocorticoids.
    Karagianni N; Tsawdaroglou N
    Oncogene; 1994 Aug; 9(8):2327-34. PubMed ID: 8036015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites.
    Wang Y; Prywes R
    Oncogene; 2000 Mar; 19(11):1379-85. PubMed ID: 10723128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
    Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
    Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential induction of the c-fos promoter through distinct PDGF receptor-mediated signaling pathways.
    Salhany KE; Robinson-Benion C; Candia AF; Pledger WJ; Holt JT
    J Cell Physiol; 1992 Feb; 150(2):386-95. PubMed ID: 1310326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and heparan sulfate inhibit extracellular signal-regulated kinase activation and myocardial cell hypertrophy induced by endothelin-1.
    Mizutani K; Kawashima S; Ueyama T; Sakoda T; Takeuchi S; Kobayashi S; Yokoyama M; Hayashi Y; Itoh H
    Kobe J Med Sci; 2001 Apr; 47(2):47-58. PubMed ID: 11599124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB.
    Murga C; Zohar M; Teramoto H; Gutkind JS
    Oncogene; 2002 Jan; 21(2):207-16. PubMed ID: 11803464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-associated changes in basal c-fos transcription factor binding activity in rat hearts.
    Tsou H; Azhar G; Lu XG; Kovacs S; Peacocke M; Wei JY
    Exp Cell Res; 1996 Dec; 229(2):432-7. PubMed ID: 8986626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
    Lo RK; Wong YH
    Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of COX-2 transcription by Ras- and Rho-family of GTPases.
    Slice LW; Bui L; Mak C; Walsh JH
    Biochem Biophys Res Commun; 2000 Sep; 276(2):406-10. PubMed ID: 11027488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galphaz inhibits serum response factor-dependent transcription by inhibiting Rho signaling.
    Dutt P; Jaffe AB; Merdek KD; Hall A; Toksoz D
    Mol Pharmacol; 2004 Dec; 66(6):1508-16. PubMed ID: 15326221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CrkII induces serum response factor activation and cellular transformation through its function in Rho activation.
    Iwahara T; Akagi T; Shishido T; Hanafusa H
    Oncogene; 2003 Sep; 22(38):5946-57. PubMed ID: 12955073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of c-fos by lipopolysaccharide in glial cells via p38 mitogen-activated protein kinase-dependent activation of serum or cyclic AMP/calcium response element.
    Simi A; Edling Y; Ingelman-Sundberg M; Tindberg N
    J Neurochem; 2005 Feb; 92(4):915-24. PubMed ID: 15686494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role for G proteins in prostate cancer cell growth and signaling.
    Kue PF; Daaka Y
    J Urol; 2000 Dec; 164(6):2162-7. PubMed ID: 11061948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells.
    Lien SC; Usami S; Chien S; Chiu JJ
    Cell Signal; 2006 Aug; 18(8):1270-8. PubMed ID: 16310342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.